Generic Name: TRAMADOL EXTENDED-RELEASE - ORAL Pronounced: (TRAH-muh-dall) Tramadol Oral Interactions
Drug interactions may change how your medications work or
increase your risk for serious side effects. This document does not contain all
possible drug interactions. Keep a list of all the products you use (including
prescription/nonprescription drugs and herbal products) and share it with your
doctor and pharmacist. Do not start, stop, or change the dosage of any
medicines without your doctor's approval.
Some products that may interact with this drug
certain pain medications (mixed narcotic agonist-antagonists
such as pentazocine, nalbuphine, butorphanol)
narcotic antagonists (such as naltrexone)
Avoid taking MAO inhibitors (isocarboxazid, linezolid,
methylene blue, moclobemide, phenelzine, procarbazine, rasagiline, selegiline,
tranylcypromine) within 2 weeks before and during treatment with this
Variability is the law of life, and as no two faces are the same, so no two bodies are alike, and no two individuals react alike and behave alike under the abnormal conditions which we know as disease.
- Sir William Osler
Finding the best medication to treat all types of low back pain is an impossible task given the variability of people and the multidimensional nature of this condition. Finding the right medication for your low back pain might not be so impossible if your individual circumstances are carefully taken into consideration. Over 80 percent of people with chronic low back pain take at least one type of medication to help relieve the pain. The top three medications used are: anti-inflammatory medications, opioid medications, and antidepressant medications . Of course, many other medications are utilized for back pain like acetaminophen, muscle relaxants, steroids, and antiepileptic medications. With so many choices, how can you find the right one that is going ...
T he study called ACCORD (Action to Control Cardiovascular Risk in Diabetes) is back in the news. The study, which included 10,251 patients with type 2 diabetes mellitus and who were at especially high risk of cardiovascular events (such as heart attacks, stroke, or death from cardiovascular disease). The study should not be extrapolated to patients with type 2 diabetes "who are younger, whose diagnosis is more recent, or who have a lower risk of CVD than participants studied in the ACCORD trials. It is not known what effect more intensive therapy might have on CVD in younger people with type 2 diabetes or in patients with a lower risk of CVD than were studied in ACCORD" (per a NIH Q&A about the study).
I have previously written (several times!) about earlier results from the ACCORD trial, which surprised experts when it was announced that patients in the tight-glucose-control part of the study (aiming for A1C below 6.0) had more deaths than patients in the standard-glucose...
You should knowAnswers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.